These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28922806)

  • 1. Linezolid as treatment for pulmonary Mycobacterium avium disease.
    Deshpande D; Srivastava S; Pasipanodya JG; Gumbo T
    J Antimicrob Chemother; 2017 Sep; 72(suppl_2):i24-i29. PubMed ID: 28922806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tedizolid is highly bactericidal in the treatment of pulmonary Mycobacterium avium complex disease.
    Deshpande D; Srivastava S; Pasipanodya JG; Lee PS; Gumbo T
    J Antimicrob Chemother; 2017 Sep; 72(suppl_2):i30-i35. PubMed ID: 28922807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minocycline treatment for pulmonary Mycobacterium avium complex disease based on pharmacokinetics/pharmacodynamics and Bayesian framework mathematical models.
    Ruth MM; Magombedze G; Gumbo T; Bendet P; Sangen JJN; Zweijpfenning S; Hoefsloot W; Pennings L; Koeken VACM; Wertheim HFL; Lee PS; van Ingen J; Deshpande D
    J Antimicrob Chemother; 2019 Jul; 74(7):1952-1961. PubMed ID: 31039251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moxifloxacin pharmacokinetics/pharmacodynamics and optimal dose and susceptibility breakpoint identification for treatment of disseminated Mycobacterium avium infection.
    Deshpande D; Srivastava S; Meek C; Leff R; Hall GS; Gumbo T
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2534-9. PubMed ID: 20385862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel ceftazidime/avibactam, rifabutin, tedizolid and moxifloxacin (CARTM) regimen for pulmonary Mycobacterium avium disease.
    Deshpande D; Srivastava S; Pasipanodya JG; Lee PS; Gumbo T
    J Antimicrob Chemother; 2017 Sep; 72(suppl_2):i48-i53. PubMed ID: 28922809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of the azithromycin and ethambutol combination regimen in the hollow-fibre system model of pulmonary Mycobacterium avium infection is due to acquired resistance.
    Srivastava S; Deshpande D; Gumbo T
    J Antimicrob Chemother; 2017 Sep; 72(suppl_2):i20-i23. PubMed ID: 28922805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 'shock and awe' thioridazine and moxifloxacin combination-based regimen for pulmonary Mycobacterium avium-intracellulare complex disease.
    Srivastava S; Deshpande D; Sherman CM; Gumbo T
    J Antimicrob Chemother; 2017 Sep; 72(suppl_2):i43-i47. PubMed ID: 28922810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarecycline pharmacokinetics/pharmacodynamics in the hollow-fibre model of Mycobacterium avium complex: so near and yet so far.
    Singh S; Boorgula GD; Aryal S; Philley JV; Gumbo T; Srivastava S
    J Antimicrob Chemother; 2024 Jan; 79(1):96-99. PubMed ID: 37946564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethambutol optimal clinical dose and susceptibility breakpoint identification by use of a novel pharmacokinetic-pharmacodynamic model of disseminated intracellular Mycobacterium avium.
    Deshpande D; Srivastava S; Meek C; Leff R; Gumbo T
    Antimicrob Agents Chemother; 2010 May; 54(5):1728-33. PubMed ID: 20231389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftriaxone Efficacy for Mycobacterium avium Complex Lung Disease in the Hollow Fiber and Translation to Sustained Sputum Culture Conversion in Patients.
    Deshpande D; Magombedze G; Boorgula GD; Chapagain M; Srivastava S; Gumbo T
    J Infect Dis; 2024 Aug; 230(2):e230-e240. PubMed ID: 38036299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azithromycin Dose To Maximize Efficacy and Suppress Acquired Drug Resistance in Pulmonary Mycobacterium avium Disease.
    Deshpande D; Pasipanodya JG; Gumbo T
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2157-63. PubMed ID: 26810646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic drug-susceptibility profiles and genetic analysis based on whole-genome sequencing of Mycobacterium avium complex isolates in Thailand.
    Sirichoat A; Kaewprasert O; Hinwan Y; Faksri K
    PLoS One; 2023; 18(11):e0294677. PubMed ID: 37992075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Sterilizing Effect of Intermittent Tedizolid for Pulmonary Tuberculosis.
    Srivastava S; Deshpande D; Nuermberger E; Lee PS; Cirrincione K; Dheda K; Gumbo T
    Clin Infect Dis; 2018 Nov; 67(suppl_3):S336-S341. PubMed ID: 30496463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The discovery of ceftazidime/avibactam as an anti-Mycobacterium avium agent.
    Deshpande D; Srivastava S; Chapagain ML; Lee PS; Cirrincione KN; Pasipanodya JG; Gumbo T
    J Antimicrob Chemother; 2017 Sep; 72(suppl_2):i36-i42. PubMed ID: 28922808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omadacycline efficacy in the hollow fibre system model of pulmonary Mycobacterium avium complex and potency at clinically attainable doses.
    Chapagain M; Pasipanodya JG; Athale S; Bernal C; Trammell R; Howe D; Gumbo T
    J Antimicrob Chemother; 2022 May; 77(6):1694-1705. PubMed ID: 35257162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thioridazine as Chemotherapy for Mycobacterium avium Complex Diseases.
    Deshpande D; Srivastava S; Musuka S; Gumbo T
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4652-8. PubMed ID: 27216055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A programme to create short-course chemotherapy for pulmonary Mycobacterium avium disease based on pharmacokinetics/pharmacodynamics and mathematical forecasting.
    Deshpande D; Srivastava S; Gumbo T
    J Antimicrob Chemother; 2017 Sep; 72(suppl_2):i54-i60. PubMed ID: 28922811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal Clinical Doses of Faropenem, Linezolid, and Moxifloxacin in Children With Disseminated Tuberculosis: Goldilocks.
    Srivastava S; Deshpande D; Pasipanodya J; Nuermberger E; Swaminathan S; Gumbo T
    Clin Infect Dis; 2016 Nov; 63(suppl 3):S102-S109. PubMed ID: 27742641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.
    Huang CC; Wu MF; Chen HC; Huang WC
    J Microbiol Immunol Infect; 2018 Oct; 51(5):636-643. PubMed ID: 28705770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic mutations in linezolid-resistant Mycobacterium avium complex and Mycobacterium abscessus clinical isolates.
    Kim SY; Jhun BW; Moon SM; Jeon K; Kwon OJ; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
    Diagn Microbiol Infect Dis; 2019 May; 94(1):38-40. PubMed ID: 30581010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.